Panacea Index Logo

Command Palette

Search for a command to run...

Randomized, controlled pilot trial of a smartphone app for smoking cessation using acceptance and commitment therapy.

Drug and alcohol dependence
January 1, 1970
Jonathan B Bricker et al. (7 authors)
Journal ArticleRandomized Controlled TrialResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

The researchers aimed to test the feasibility, acceptability, preliminary efficacy, and mechanism of behavioral change of a smartphone-delivered ACT application (SmartQuit) for smoking cessation compared to a standard guideline-based application (QuitGuide).

Results Summary

SmartQuit showed higher engagement (37.2 vs. 15.2 app opens) and promising quit rates (13% vs. 8%) compared to QuitGuide, particularly among participants with low baseline acceptance of cravings (15% vs. 8%). The results suggest ACT delivered via smartphone may be more effective than standard approaches, though the pilot design limits conclusions.

Population

Adult smokers recruited nationally (n=196).

Effective Dosage

Not specified

Duration

Not specified

Interactions

None mentioned

Extracted Claims (6)
InterventionDirectionEndpointPopulationDosageImpactClaim #
smartphone-delivered acceptance and commitment therapy (ACT) application for smoking cessation (SmartQuit)
increase
application engagement
adult participants
37.2 times
participants opened their application an average of
#1
National Cancer Institute's application for smoking cessation (QuitGuide)
increase
application engagement
adult participants
15.2 times
participants opened their application an average of
#2
smartphone-delivered acceptance and commitment therapy (ACT) application for smoking cessation (SmartQuit)
increase
smoking cessation
adult participants
13%
quit rates were
#3
National Cancer Institute's application for smoking cessation (QuitGuide)
increase
smoking cessation
adult participants
8%
quit rates were
#4
smartphone-delivered acceptance and commitment therapy (ACT) application for smoking cessation (SmartQuit)
increase
smoking cessation
those scoring low (below the median) on acceptance of cravings at baseline
15%
quit rates were
#5
National Cancer Institute's application for smoking cessation (QuitGuide)
increase
smoking cessation
those scoring low (below the median) on acceptance of cravings at baseline
8%
quit rates were
#6
Abstract

BACKGROUND: There is a dual need for (1) innovative theory-based smartphone applications for smoking cessation and (2) controlled trials to evaluate their efficacy. Accordingly, this study tested the feasibility, acceptability, preliminary efficacy, and mechanism of behavioral change of an innovative smartphone-delivered acceptance and commitment therapy (ACT) application for smoking cessation vs. an application following US Clinical Practice Guidelines. METHOD: Adult participants were recruited nationally into the double-blind randomized controlled pilot trial (n=196) that compared smartphone-delivered ACT for smoking cessation application (SmartQuit) with the National Cancer Institute's application for smoking cessation (QuitGuide). RESULTS: We recruited 196 participants in two months. SmartQuit participants opened their application an average of 37.2 times, as compared to 15.2 times for QuitGuide participants (p<0001). The overall quit rates were 13% in SmartQuit vs. 8% in QuitGuide (OR=2.7; 95% CI=0.8-10.3). Consistent with ACT's theory of change, among those scoring low (below the median) on acceptance of cravings at baseline (n=88), the quit rates were 15% in SmartQuit vs. 8% in QuitGuide (OR=2.9; 95% CI=0.6-20.7). CONCLUSIONS: ACT is feasible to deliver by smartphone application and shows higher engagement and promising quit rates compared to an application that follows US Clinical Practice Guidelines. As results were limited by the pilot design (e.g., small sample), a full-scale efficacy trial is now needed.

Medical Subject Headings (MeSH)
Acceptance and Commitment TherapyAdultBehavior, AddictiveCell PhoneDouble-Blind MethodFemaleHumansMaleMobile ApplicationsPilot ProjectsSmoking CessationTherapy, Computer-AssistedTreatment Outcome
Study Links
Quality Scores
SafetyNot Assessed
Efficacy65/10
Quality75/10
Citation Metrics
Total Citations231
Citations/Year21.0
Relative Citation Ratio11.17
NIH Percentile98.2%
Research Impact Scores
APT Score0.95
Weight Score1.98
Normalized Score0.61
Related Supplements
Randomized, controlled pilot trial of a smartphone app for s... | Panacea Index